BiondVax Pharmaceuticals Ltd.

2.93-0.1500-4.87%Vol 179.72K1Y Perf -69.08%
Apr 20th, 2021 16:00 DELAYED
BID2.94 ASK3.15
Open3.08 Previous Close3.08
Pre-Market- After-Market-
 - -  - -%
Target Price
81.00 
Analyst Rating
— 0.00
Potential %
2.66K 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap33.27M 
Earnings Rating
Neutral
Price Range Ratio 52W %
0.97 
Earnings Date
5th Jan 2021

Today's Price Range

2.903.08

52W Range

2.3562.00

5 Year PE Ratio Range

-5.40-2.60

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-14.08%
1 Month
-31.22%
3 Months
-50.76%
6 Months
-92.11%
1 Year
-69.08%
3 Years
-55.61%
5 Years
-22.89%
10 Years
-

TickerPriceChg.Chg.%
BVXV2.93-0.1500-4.87
AAPL133.11-1.7300-1.28
GOOG2 293.63-8.7700-0.38
MSFT258.26-0.4800-0.19
XOM55.29-1.1900-2.11
WFC42.54-1.3400-3.05
JNJ166.483.79002.33
FB302.650.41000.14
GE13.06-0.4000-2.97
JPM149.27-3.3800-2.21
Earnings HistoryEstimateReportedSurprise %
Q03 2020--0.01-
Q02 2020-0.01-1.12-11 100.00
Q01 2020-0.01-0.08-700.00
Q04 2019--1.25-
Q03 2019-0.03-0.57-1 800.00
Q02 2019-0.02-2.02-10 000.00
Q01 2019-0.02-
Q04 2018--1.81-
Earnings Per EndEstimateRevision %Trend
9/2020 QR-0.010.00-
12/2020 QR-0.010.00-
12/2020 FY-0.060.00-
12/2021 FY-0.060.00-
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume179.72K
Shares Outstanding11.35M
Trades Count633
Dollar Volume2.44M
Avg. Volume906.57K
Avg. Weekly Volume188.08K
Avg. Monthly Volume208.23K
Avg. Quarterly Volume871.26K

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) stock closed at 2.93 per share at the end of the most recent trading day (a -4.87% change compared to the prior day closing price) with a volume of 179.89K shares and market capitalization of 33.27M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 25 people. BiondVax Pharmaceuticals Ltd. CEO is Ron Babecoff.

The one-year performance of BiondVax Pharmaceuticals Ltd. stock is -69.08%, while year-to-date (YTD) performance is 4.27%. BVXV stock has a five-year performance of -22.89%. Its 52-week range is between 2.35 and 62, which gives BVXV stock a 52-week price range ratio of 0.97%

BiondVax Pharmaceuticals Ltd. currently has a PE ratio of -2.40, a price-to-book (PB) ratio of 8.87, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -33.14%, a ROC of -% and a ROE of 284.00%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from BiondVax Pharmaceuticals Ltd., there were 0 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. BiondVax Pharmaceuticals Ltd.’s next earnings report date is -.

The consensus rating of Wall Street analysts for BiondVax Pharmaceuticals Ltd. is (0), with a target price of $81, which is +2 664.51% compared to the current price. The earnings rating for BiondVax Pharmaceuticals Ltd. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BiondVax Pharmaceuticals Ltd. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

BiondVax Pharmaceuticals Ltd. has a Sell technical analysis rating based on Technical Indicators (ADX : 22.12, ATR14 : 0.47, CCI20 : -173.78, Chaikin Money Flow : -0.37, MACD : -0.41, Money Flow Index : 24.98, ROC : -18.95, RSI : 34.39, STOCH (14,3) : 8.00, STOCH RSI : 0.18, UO : 29.23, Williams %R : -92.00), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BiondVax Pharmaceuticals Ltd. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating--Strong Buy
1.00

BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.

CEO: Ron Babecoff

Telephone: +972 89302529

Address: Hadassah Ein Kerem Campus, Jerusalem 74036, , IL

Number of employees: 25

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

75%25%

Bearish Bullish

59%41%

Bearish Bullish

59%41%

News

Stocktwits